Menu
GeneBe

PCNT

pericentrin

Basic information

Region (hg38): 21:46324123-46445769

Previous symbols: [ "PCNT2" ]

Links

ENSG00000160299NCBI:5116OMIM:605925HGNC:16068Uniprot:O95613AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • microcephalic osteodysplastic primordial dwarfism type II (Definitive), mode of inheritance: AR
  • Moyamoya disease (Moderate), mode of inheritance: AR
  • microcephalic osteodysplastic primordial dwarfism type II (Definitive), mode of inheritance: AR
  • microcephalic osteodysplastic primordial dwarfism type II (Strong), mode of inheritance: AR
  • microcephalic osteodysplastic primordial dwarfism type II (Supportive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Microcephalic osteodysplastic primordial dwarfism, type IIARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Musculoskeletal; Neurologic7201238; 9800906; 9800908; 12400072; 12210304; 15368497; 15372530; 18157127; 18174396; 20358609; 19643772; 21567919
Individuals may have cerebral neurovascular anomalies

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PCNT gene.

  • not provided (149 variants)
  • Microcephalic osteodysplastic primordial dwarfism type II (39 variants)
  • Inborn genetic diseases (4 variants)
  • PCNT-related disorder (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PCNT gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
15
clinvar
989
clinvar
31
clinvar
1035
missense
772
clinvar
67
clinvar
36
clinvar
875
nonsense
78
clinvar
14
clinvar
2
clinvar
94
start loss
0
frameshift
91
clinvar
17
clinvar
7
clinvar
115
inframe indel
26
clinvar
5
clinvar
31
splice donor/acceptor (+/-2bp)
7
clinvar
39
clinvar
1
clinvar
47
splice region
28
125
13
166
non coding
1
clinvar
21
clinvar
485
clinvar
162
clinvar
669
Total 176 71 844 1546 229

Highest pathogenic variant AF is 0.0000460

Variants in PCNT

This is a list of pathogenic ClinVar variants found in the PCNT region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
21-46324123-CG-C Microcephalic osteodysplastic primordial dwarfism Benign (Jun 14, 2016)340455
21-46324123-C-CG Microcephalic osteodysplastic primordial dwarfism Uncertain significance (Jun 14, 2016)340454
21-46324154-G-A Microcephalic osteodysplastic primordial dwarfism Uncertain significance (Jun 14, 2016)340456
21-46324194-T-A Microcephalic osteodysplastic primordial dwarfism type II Uncertain significance (Jan 12, 2018)340457
21-46324196-A-G Microcephalic osteodysplastic primordial dwarfism type II Uncertain significance (Jan 13, 2018)899366
21-46324204-G-C Microcephalic osteodysplastic primordial dwarfism type II Likely benign (Jan 13, 2018)340458
21-46324213-G-T not specified • Microcephalic osteodysplastic primordial dwarfism type II Benign (Jan 12, 2018)138617
21-46324214-C-G Likely benign (Apr 19, 2018)669290
21-46324223-A-T PCNT-related disorder Likely benign (Apr 07, 2021)3042562
21-46324235-G-A Inborn genetic diseases Uncertain significance (Nov 18, 2023)3210381
21-46324235-G-C Microcephalic osteodysplastic primordial dwarfism type II Likely benign (Apr 28, 2021)1330623
21-46324244-G-C not specified • Microcephalic osteodysplastic primordial dwarfism type II Uncertain significance (Jul 01, 2020)436252
21-46324249-G-A Likely benign (Feb 22, 2023)2802826
21-46324250-CGGCGCAGAAA-C Pathogenic (Mar 02, 2023)2842161
21-46324252-G-A Likely benign (May 19, 2023)3012548
21-46324252-G-C PCNT-related disorder Conflicting classifications of pathogenicity (Dec 12, 2023)282936
21-46324255-C-T Likely benign (Nov 13, 2023)2974053
21-46324257-G-C PCNT-related disorder Uncertain significance (Jan 11, 2024)3061468
21-46324261-G-A Likely benign (Jan 31, 2024)2955736
21-46324264-G-A Likely benign (Sep 08, 2023)2713023
21-46324273-G-A Likely benign (Jan 31, 2024)2880569
21-46324273-G-C Likely benign (Jan 02, 2024)2836290
21-46324274-A-C Likely benign (Apr 28, 2023)2859900
21-46324276-G-A Likely benign (Feb 01, 2024)1629998
21-46324277-A-G not specified Likely benign (Jun 09, 2017)517931

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PCNTprotein_codingprotein_codingENST00000359568 47121647
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
4.02e-580.47612538313641257480.00145
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.7320931.88e+31.110.00012921658
Missense in Polyphen172179.540.958022051
Synonymous-4.529758111.200.00005896485
Loss of Function3.531171660.7050.000009011901

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.002780.00278
Ashkenazi Jewish0.006950.00368
East Asian0.0005440.000544
Finnish0.0002040.000185
European (Non-Finnish)0.001380.00128
Middle Eastern0.0005440.000544
South Asian0.002820.00281
Other0.001960.00179

dbNSFP

Source: dbNSFP

Function
FUNCTION: Integral component of the filamentous matrix of the centrosome involved in the initial establishment of organized microtubule arrays in both mitosis and meiosis. Plays a role, together with DISC1, in the microtubule network formation. Is an integral component of the pericentriolar material (PCM). May play an important role in preventing premature centrosome splitting during interphase by inhibiting NEK2 kinase activity at the centrosome. {ECO:0000269|PubMed:10823944, ECO:0000269|PubMed:11171385, ECO:0000269|PubMed:18955030, ECO:0000269|PubMed:20599736}.;
Disease
DISEASE: Microcephalic osteodysplastic primordial dwarfism 2 (MOPD2) [MIM:210720]: Adults with this rare inherited condition have an average height of 100 centimeters and a brain size comparable to that of a 3-month-old baby, but are of near-normal intelligence. {ECO:0000269|PubMed:18157127, ECO:0000269|PubMed:18174396}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Olfactory bulb development and olfactory learning;Regulation of PLK1 Activity at G2/M Transition;Recruitment of mitotic centrosome proteins and complexes;Loss of Nlp from mitotic centrosomes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;AURKA Activation by TPX2;G2/M Transition;Mitotic G2-G2/M phases;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;M Phase;Cell Cycle;Cell Cycle, Mitotic;Anchoring of the basal body to the plasma membrane;Cilium Assembly;Organelle biogenesis and maintenance (Consensus)

Recessive Scores

pRec
0.214

Intolerance Scores

loftool
0.898
rvis_EVS
3.57
rvis_percentile_EVS
99.52

Haploinsufficiency Scores

pHI
0.122
hipred
Y
hipred_score
0.519
ghis
0.463

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.898

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Pcnt
Phenotype
growth/size/body region phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype;

Gene ontology

Biological process
G2/M transition of mitotic cell cycle;microtubule cytoskeleton organization;mitotic spindle organization;signal transduction;regulation of G2/M transition of mitotic cell cycle;cilium assembly;positive regulation of intracellular protein transport;ciliary basal body-plasma membrane docking
Cellular component
centrosome;centriole;microtubule organizing center;cytosol;microtubule;membrane;centriolar satellite
Molecular function
protein binding;calmodulin binding;protein-containing complex scaffold activity